Phase Two Safety and Efficacy Study of Single Dose Intravesical Resiniferatoxin in Patients with Interstitial Cystitis

Payne C1, Mosbaugh P2, Forrest J3, Evans R3, Frumkin L4 1. Stanford University, 2. Indiana University, 3. none, 4. ICOS Corporation

Abstract Category

Painful Bladder Syndromes/IC

Abstract 148
Clinical Pharmacology and Overactivity - Blue Room:Chaired by Harold Drutz and Alan Wein
Scientific Podium Poster Session 16
Friday 27th August 2004
15:09 - 15:17
Links

Abstract

29/03/2024 06:40:52